DTE vs ISPC
DTE (DTE) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
DTE does not have a complete income-statement cache yet.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
DTE currently screens at market cap $0. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the DTE and ISPC stock pages for the full models.
Not investment advice.